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Abstract
Background: Chinese licorice, (Glycyrrhiza uralensis Fisch.) is one of the commonly prescribed herbs in Traditional
Chinese Medicine (TCM). Gancao, as commonly known in China, is associated with immune-modulating and
anti-tumor potential though the mechanism of action is not well known. In this study, we investigated the in vitro
immunomodulatory and antitumor potential of Glycyrrhiza uralensis polysaccharides fractions of high molecular
weight (fraction A), low molecular weight (fraction B) and crude extract (fraction C).
Methods: Cell proliferation and cytotoxicity was investigated using Cell Counting kit 8 (CCK-8) on Intestinal
epithelial cell line (IEC-6) and Colon carcinoma cell line (CT-26). IL-7 gene expression relative to GAPDH was
analysed using Real time PCR. The stimulation and viability of T lymphocytes was determined by Trypan blue
exclusion assay.
Results: G.uralensis polysaccharides did not inhibit proliferation of IEC-6 cells even at high concentration. The ED50
was found to be 100 μg/ml. On the other hand, the polysaccharides inhibited the proliferation of cancer cells
(CT-26) at a concentration of ≤50 μg/ml. Within 72 h of treatment with the polysaccharides, expression of IL-7 gene
was up-regulated over 2 times. It was also noted that, IEC-6 cells secrete IL-7 cytokine into media when treated
with G.uralensis polysaccharides. The secreted IL-7 stimulated proliferation of freshly isolated T lymphocytes within
6 h. The effect of the polysaccharides were found to be molecular weight depended, with low molecular weight
having a profound effect compared to high molecular weight and total crude extract.
Conclusion: Our findings indicate that G.uralensis polysaccharides especially those of low molecular weight have a
potential as anticancer agents. Of great importance, is the ability of the polysaccharides to up-regulate anticancer
cytokine IL-7, which is important in proliferation and maturation of immune cells and it is associated with better
prognosis in cancer. Therefore, immunomodulation is a possible mode of action of the polysaccharides in cancer
therapy.
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Background
Cancer is a leading cause of death worldwide. According
to Global cancer burden, there are estimated 12.7 million
new cases and 7.6 million death, translating to 70 %
increase in new cases and death [1]. It is projected that
there will be an increase from 12.7 to 21.4 new cancer
cases in the year 2030 [2]. In the United states, there were
estimated1,665,540 new cancer cases and 585,720 cancer
death in 2014 [3]. Cancer causes are complex but there
are risk factors which contribute to its pathophysiology
[4]. Due to this, cancer can be regarded to as a preventable
disease since approximately 90–95 % of the cases are
attributed to environmental factors and the remaining
fraction is due to genetics. [4].
The prevention and management of cancer through
surgery, radiotherapy, chemotherapy, hormonotherapy
and complementary therapies have yielded varying
results. Notably, conventional therapies lead to second-
ary complications especially metastasis, reduced immune
competence, recurrence of tumors and decrease of qual-
ity of life (QOL) of patients [5–8]. Due to the varying
effects of conventional treatments, lack of awareness and
poverty, a great percentage of the world’s population
uses alternative and complementary medicine for man-
agement and treatment of cancer [9, 10]. Among the
complementary and alternative medicine, Traditional
Chinese medicine (TCM), a holistic approach that
focuses on improving body’s immune system to fight
diseases, has been used to treat various diseases over
thousands of years in East Asian countries. For instance,
a number of different kinds of cancer have been treated
with TCM drugs either alone or in combination with
conventional therapies [11, 12]. Glycyrrhiza uralensis
Fisch. is one of the oldest prescribed herb in Chinese
traditional medicine for the treatment of various disease
syndromes including cancer, by arresting tumorigenesis
and metastasis [13–18]. Glycyrrhiza uralensis belongs to
the Family Fabaceae (Leguminosae), genus Glycyrrhiza and
species Glycyrrhiza glabra, Glycyrrhiza lepidota, and
Glycyrrhiza uralensis found in Europe, Asia, Russia and
Turkey where its roots are commonly used. It has phenolic
compounds, triterpenes, saponins, flavonoids, polysaccha-
rides, pectines and amino acids among others [19, 20].
Studies on Glycyrrhizae have shown potential of its
compounds as anticancer and immune booster in vitro
and in vivo. For instance, isoliquiritigenin reduces the
multiplication of colon and lung cancer [21], glycyrrhizin
and glabridin have anti-proliferative and apoptosis indu-
cing properties against MCF-7 and HEP-2 cells [22, 23],
chalconeisoliquiritigenin show antitumorigenic potential
on prostate and breast cancer [24, 25], 18β-glycyrrhetinic
acid up-regulates T cell proliferation and enhances the
immune status by increasing blood leukocyte count and
weight of the spleen when administered to mice [26–28].
The anti-cancer mechanism of Licorice compounds is
not well known but it can be associated with augment-
ing T cell proliferation and modulating the immune
system through stimulation and secretion of cytokine
IL-7 which is associated with maturation, proliferation
and maintenance of homeostasis of lymphocyte lineage
cells. Research indicates that cytokines have a broad
mechanism of action in cancer treatment. Due to this
knowledge, a number of cytokines based therapies for
cancer treatment have been developed. Among other
cytokines, IL-7 has entered clinical trials for having a
potential for adoptive immunotherapy in cancer therapy
[29–31]. Interleukin 7 induces proliferation and long-term
survival of freshly isolated T cells, Naïve and memory T
cells, making it an essential cytokine in lymphopoeisis and
homeostasis of T lymphocytes [32–34]
This study evaluated the antitumor and immunomod-
ulatory potential of G.uralensis polysaccharides. The aim
is to determine the effect of the polysaccharides on IL-7
gene expression, effect of IL-7 on proliferation of T lym-
phocytes and inhibitory potential of the polysaccharides
on cancer cells.
Methods
All chemical reagents were purchased from Sigma
(Sigma-Aldrich Inc., St. Louis, MO, USA unless otherwise
stated). Mouse Intestinal Epithelial cell line (IEC-6) and
colon carcinoma cell line (CT-26) were provided by
Institute of animal research in Beijing, China; Dulbecco’s
Modified Eagle’s Medium (DMEM), Fetal bovine serum
(FBS), Streptomycin/Penicillin and Insulin were purchased
from Gibco, Beijing, China; synthetic oligonucleotides
primers were purchased from Sangon Biotech (Shanghai)
Co., Ltd). Glycyrrhiza uralensis polysaccharide extracts
were provided by the Tianjin University ofTraditional
Chinese Medicine(TUTCM) herbal pharmaceutical
company, Tianjin, China. The polysaccharides were
fraction A of over 100 kDa was 81.4 % (High molecular
weight), fraction B, of 75 kDa was 45.4 and 54.6 %
polysaccharide fractions was under 10 kDa (Low molecu-
lar weight) and fraction C, 34.5 % polysaccharide fractions
was 290 kDa and 14 kDa was 30.3 %, total crude extract.
Cell counting kit - CCK-8 (Dojindo Molecular Technolo-
gies, Beijing, China); Trizol (Invitrogen); QuantScript RT
Kit (TIANGEN, Beijing, China); SuperRealPreMix SYBR
Green (TIANGEN BIOTECH (BEIJING) CO.,LTD); Micro-
titerplate reader, VarioskanFlash.
Cell lines and Cell culture
Mouse intestinal epithelial cell line (IEC-6) were routinely
maintained in Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 1 % streptomycin/penicillin
(P/S), 1 % insulin and 10 % Fetal Bovine Serum (FBS) at
37 °C and 5 % CO2. Colon carcinoma cell line (CT-26)
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were routinely maintained in RPMI-1640 supplemented
with 1 % streptomycin/penicillin (P/S), L- glutamine and
10 % Fetal Bovine Serum (FBS) at 37 °C and 5 % CO2. All
cell lines were maintained in a humidified atmosphere.
Standard cell culture protocols for cell culture were
followed at the TUTCM laboratories.
Antitumor and proliferative effect of G. uralensis
polysaccharides
Proliferation and cytotoxicity of cells was determined
using a CCK-8 assay (Dojindo Molecular Technologies,
Beijing, China). A total density of approximately 5 × 103
cells/well of IEC-6 and CT-26 were seeded in 96 well
plates for 24 h. They were treated with different concen-
trations of Licorice polysaccharides at 10 μL per well
and incubated at 37 °C, 5 % CO2 for 3 days. Subse-
quently, 10 μL of CCK-8 was added to each well,
incubated in a high humidity environment at 37 °C and
5 % CO2 for 4 h. The absorbance was measured at a
wavelength of 450 nm using a microtiter plate reader
(VarioskanFlash using Skanlt software 2.4.3KE).
IL-7 gene expression analysis by Real time polymerase
chain reaction
To determine the immunomodulatory potential of G.
uralensis polysaccharides through expression and secre-
tion of IL-7, expression of IL–7 cytokine was evaluated
by Real time PCR assay as previously described [35].
Briefly, IEC-6 cells were cultured in six well plates (2 ×
105) maintained in DMEM (Gibco) supplemented with
various extracts at concentrations of 100 μg/ml at 3
and 72 h. After the treatment period, RNA was isolated
using RNeasy total RNA extraction Kit (Qiagen, Beijing,
China). cDNA was synthesised using QuantScript RT
Kit (TIANGEN, Beijing, China) according to manufac-
turer’s instructions. Real time PCR assay was carried
out using IQ5 Multicolor thermocycler (BIO-RAD
Laboratories, Beijing) using SuperReal Premix SYBR
Green I (TIANGEN BIOTECH (BEIJING) CO., Ltd)
following manufacturer’s TIANGEN instruction kit.
The synthetic oligonucleotides primers were; IL 7: (F)
5 GAGTTTCAGACGGCACACAA 3 and (R) 5 GA
AACTTCTGGGAGGGTTCC 3 (product size: 229 bp)
and GAPDH: (F) 5 CCACAGTCCATGCCATCAC 3 and
(R) 5 TCCACCACCCTGTTGCTGTA 3 (product
size: 452 bp). The PCR conditions and amplification
efficiency for the genes were optimized at 95–98 %. Two
step protocol was used, 95 °C for 15 min; 95 °C for 10 s
and 60 °C for 32 s followed by Dissociation curve. Expres-
sion of the gene was analysed by the IQ5 Mutlicolor Real
time PCR Software as the relative expression of IL-7 of
GAPDH.
Isolation of Lymphocytes and Lymphocyte activation
assay
To determine secretion of IL-7 by IEC-6 cells treated
with Licorice polysaccharides and proliferation of T cells
stimulated by IL-7, Trypan exclusion assay and lympho-
cyte activation assay was done. Briefly, Rectal-orbital
puncture method was used to draw blood from anaes-
thetised rat into anticoagulant treated tubes. A modifica-
tion of lymphocyte isolation assay by density gradient
centrifugation Ficoll-paque was used to isolate lym-
phocytes [36, 37]. The lymphocytes were cultured in
supernatants of IEC-6 cells treated with G.uralensis
polysaccharides, seeded in 24 well plates at a density of
1 × 104 cells/ml and ratio of 1:1. As an internal control,
IL-7 mouse antibodies were added to culture wells to
block stimulation by IL-7 cytokine. After 6 h of incu-
bation, the cell number and viability was determined
by Trypan blue exclusion assay.
Statistical analysis
Analysis of the results was done using SPSS statistical
software version 16 and curve-fitting was done using
GraphPadprism version 5. ANOVA was used to compare
the means of different groups. Mean separation was
carried out to determine the level of significance. The
data are expressed as mean ± S.E.M. P-value of ≤ 0.05
was considered statistically significant.
Results
Proliferation of IEC-6 cells
The proliferation and viability of IEC-6 cell line was
measured by (CCK-8) assay. Proliferation of cells was
determined as a percentage of viable treated cells in
comparison to viable untreated controls. It was deter-
mined that G.uralensis polysaccharide extracts stimu-
lated proliferation of IEC-6 cells in vitro. The optimum
growth for IEC-6 cells was found to be 1 μg/ml, how-
ever, the ED50 was determined to be approximately
100 μg/ml. Interestingly, Glycyrrhiza uralensis polysac-
charides stimulated proliferation of epithelial cells even at
higher concentration of 100 μg/ml. Notably, there was no
significant difference between proliferation activity of the
three polysaccharide fractions, but, low molecular weight
polysaccharides stimulated proliferation of epithelial cells
more than the high molecular weight polysaccharides
(Fig. 1). Furthermore, licorice polysaccharides showed little
or no cytotoxic effects on the epithelial cells unless at obvi-
ously very high concentration.
G.uralensis polysaccharides inhibits proliferation of colon
carcinoma cell line (CT-26)
We investigated whether G.uralensis polysaccharides has
the same effect of promoting proliferation of epithelial
cells on cancer cell lines. Colon cancer cell line (CT-26)
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was treated with different concentrations of G.uralensis
polysaccharides. The polysaccharides showed significant
antitumor effects after 72 h. At a concentration of
0.05 mg/ml, growth inhibition was evident (Fig. 2) with
nearly 50 % growth inhibition of cancer cells compared
to epithelial cells, IEC-6, (Fig. 2). Comparing the three
extracts, Fraction B, which is polysaccharide of lower
molecular weight showed a higher inhibitory activity
than the other fractions, A and C with more than 50 %
of the growth inhibition of CT-26 cells at 0.1 mg/ml
(Fig. 2). The results indicate that, while the licorice
polysaccharides stimulate proliferation of normal cells
(IEC-6), they inhibit growth of cancer cells even at low
concentration.
G.uralensis polysaccharides up-regulates expression of
Interleukin 7
To investigate the immunomodulatory effect of G.uralensis
polysaccharides through upregulation of IL-7 gene, the
expression level of IL-7 in licorice polysaccharide treated
IEC-6 cells was determined. The IEC-6 cells treated with
Fig. 1 Effect of polysaccharides on IEC-6 viability and proliferation.
IEC-6 cells (5 × 104cells/ml) stimulated by polysaccharides (Fraction
a, b & c) with concentration range of 0.001 μg/ml to 100 μg/ml for
72 h at 37°C, 5 % CO2- Cell viability measured by CCK-8 assay. Data
expressed as mean ± S.E.M of three tests done in triplicate
Fig. 2 In vitro direct cytotoxic effect of Gancao polysaccharide extracts. Decrease in cell number was observed in CT 26 cells (5 × 104 cells /ml)
upon treatment with various concentration of polysaccharides (Fraction a, b and c) from 0.05 mg/ml to 0.8 mg/ml as measured by CCK-8 assay.
Data expressed as mean ± SEM of three experiments. *P < 0.05, **P < 0.01 versus control
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G.uralensis polysaccharides showed up-regulation of the
IL-7 gene after 3 h and the upregulation remained elevated
upto 72 h of treated. The up regulation of these cytokine
was depended on the molecular weight of the extracts,
going up by over two times with fraction B (Fig. 3). The up-
regulation of the cytokine was not time dependent, at 3 and
72 h, the up-regulation was not significantly different
(Fig. 3a and b).
Interleukin 7 enhances T lymphocyte proliferation
We sought to establish whether the activation and pro-
liferation of T lymphocytes was due to secreted interleu-
kin 7. After a 6 h incubation of the T lymphocytes with
various supernatants derived from IEC-6 cells treated
with G.uralensis polysaccharides, the T lymphocytes
number was determined as a measure of activation and
proliferation. From the results, all supernatants of IEC-6
cells treated with G.uralensis polysaccharide showed a
slight increase in number of T lymphocytes (Fig. 4). Low
molecular weight polysaccharide Fraction B, showed a
higher proliferation activity among the three fractions,
though there was no significant difference between these
fractions.
Discussion
This study focused on determining the anticancer potential
of polysaccharides from Chinese licorice which is a major
guiding drug in many Chinese herbal prescriptions.
Immunomodulation has been recognised as an import-
ant molecular mechanism targeting control of cancers
especially by use of cytokines.
Glycyrrhiza uralensis has been used and fronted as an
anticancer agent. Apart from its pharmacological applica-
tion, Gancao, as known in China, has been used as a
flavoring agent and sweetening agent in tobaccos, chewing
gums, candies, and toothpaste among other uses [38, 39].
G. uralensis is used as a flavouring agent to disguise the
unpleasant taste and smell of other drugs. Apart from the
medicinal properties, Gan cao is used as food, a reason that
can be attributed to the non toxicity of its polysaccharides
on gut mucosal cells. This was confirmed from our study
where the Gancao polysaccharides showed no cytotoxic
effects on normal gut cells, IEC-6 cells (Fig. 1). It was
observed that the polysaccharides fraction from Gan cao
stimulated proliferation of Intestinal epithelial cells. These
polysaccharides are therefore safe for consumption both as
dietary suppliments or food and herbal prescriptions.
G. uralensis is used in the treatment of various diseases
[40]. In Japan and China, apart from its pharmaceutical
application, it is used as a sweetening and flavouring agent
in pharmaceutical industries. It is used to treat various
ailments and diseases including cancer. The mechanism
Fig. 3 Expression of IL 7mRNA at (a) 3 h and (b) 72 h. 100 μg/ml of each polysaccharide fraction was added to IEC-6 cells and incubated for 3
and 72 h respectively. The normalized relative expression of IL-7 mRNA was analyzed by IQ5 Real-time PCR software. Data presented as mean ±
S.E.M. *P < 0.05 versus untreated (control) of three experiments
Fig. 4 Activation and proliferation of T lymphocytes by secreted IL-7
Freshly isolated T lymphocytes maintained in supernatants of IEC-6
polysaccharide treated cells. Data represented as mean ± S.E. of
two experiments
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of action in cancer treatment are varied including apop-
totic cell death through upregulation of p53 and p21, cell
cycle arrest, suppression of nitric oxide production among
others [41–44]. The antitumor activity of Gan cao was
evident when tumor cells (CT-26 cells) were exposed to
these polysaccharides. The cell growth was inhibited
even at low concentration of 0.05 mg/ml. The inhib-
ition was dependent on the molecular weight of the
polysaccharides with low molecular weight polysaccha-
rides showing a higher growth inhibition compared to
the other polysaccharides (Fig. 2). It is therefore para-
mount to link Gan cao polysaccharides to direct activity on
tumor cells. This antitumor activity is true for polysaccha-
rides especially low molecular weight polysaccharides
which have been proven to have immunomodulation and
antitumor activity [45]. Though it has been shown that
polysaccharides do not have direct effect on cancer cells
(Wasser 2002), our study showed that Licorice polysac-
charide directly inhibited growth of CT-26 tumor cells but
not IEC 6 cells in vitro at a concentration of 0.05 mg/ml.
Fraction B of low molecular weight inhibited proliferation
of CT-26 cells in a dose-dependent manner and at less
than 0.1 mg/ml concentration, its cytotoxicity effect was
half in comparison to other fractions. The results
concurred with earlier findings confirming the antitumor
potential of Gan cao polysaccharides [46–48].
Gan cao has previously been associated with antican-
cer, antioxidant and anti-inflammatory effects. Among
its mode of action, immunomodulation has been
exhibited by Gancao [42, 49, 50]. The effect of Gan cao
polysaccharide on IL-7 has not been explored. IL-7 is
an important cytokine in cancer immunotherapy and it
has potential for adoptive immunotherapy [51]. Inter-
leukin 7 homeostasis determines host survival and is
an indicator of host immunocompetence. Increased
levels of IL-7 leads to T cell activation and lack of IL-7
leads to severe immunodeficiency [52, 53]. A part from
bone marrow and other sites of production, intestinal
epithelial cells have recently been identified as a major
site of secretion [54–56]. From our experiments,
epithelial cells cultured with licorice polysaccharides
up-regulated the expression of IL-7 cytokine. The
expression was elevated at 3 h and remained elevated
up to 72 h by two times compared to the untreated
controls (Fig. 3). Augmented expression of IL-7 trans-
lates to increased circulation of IL-7 protein. IL-7
produced in the gut initiates local immune response
and promote overall immune activity to pathogens
through stimulation and maturation of T lymphocytes
[57]. Cytokines like IL-7, when secreted, stimulate
immune effector cells and enhance tumor cell recogni-
tion by cytotoxic effector cells [31]. The elevated expression
of IL-7 cytokine therefore is an indicator of the immuno-
modulatory potential of Gancao polysaccharides. Earlier
research has shown, in vitro and in vivo, IL-7 is responsible
for development, maturation, proliferation and homeostasis
of T lymphocytes [58, 59]. These findings are in agreement
with our results, in which freshly isolated T lymphocytes
cultured in supernatants containing secreted IL-7, though
to a slight extend, enhanced proliferation of lymphocytes.
We can therefore confirm that, IL-7 secreted by IEC 6 cells
treated with Gan cao polysaccharides can enhance prolifer-
ation of T lymphocytes (Fig. 4). The proliferation of T
lymphocytes leads to CD4+ and CD8+ infiltration of tumors
which is associated with better prognosis [60]. Further-
more, histology of tumors from IL-7–treated mice show
heavy infiltration with both CD4+ and CD8+ T cells [61].
Protection against tumor progression and metastasis is
attributed to cellular immunity due to CD4+ nad CD8+
cells [62]. Population and function of tumor specific CTL
are enhanced by presence of tumor specific CD4+ T cell
responses, their lack leads to tumor progression and abro-
gates the survival of tumor bearing hosts. It involves CD8+
as key effector cells of which CD4+ plays an important
role in their production, expansion maintenance and acti-
vation. The end results of combined CD4+ and CD8+ is
better than one, though CD4+ is essential for effective an-
titumor CTL responses by enhancing their number and
function. In addition to enhancing responses of CD8+ T
cell responses, CD4+ mediate tumor rejection through
cytotoxic effect on tumor cells, up regulation of MHC
molecules expression, inhibition of angiogenesis and
induction of tumor dormancy [63, 64]. It is therefore
paramount that the upregulation of IL-7 leads to augmen-
tation of T lymphocytes which are important in cancer
immunotherapy.
Conclusion
A major finding of our research is that licorice polysaccha-
rides have an antitumor and immunomodulatory activity.
They stimulate proliferation of IEC-6 cells which are major
sites of IL-7 production. These polysaccharides have a
direct antitumor potential as they inhibit proliferation of
tumor cells, CT-26, even at low concentration. Immuno-
modulatory potential of these polysaccharides is exhibited
through up-regulation of the relative expression of IL-7
gene, the immune cytokine, IL-7. This cytokine has been
fronted for enhancement, maturation, proliferation and
long survival of immune effector T cells. Finally, Gan cao
polysaccharides can enhance secretion of IL-7 cytokine by
IEC-6, which subsequently indicates that this cytokine has
the potential of promoting proliferation of T lymphocytes.
From these finding, we can therefore propose that Gan cao
polysaccharides have direct anticancer potential on tumor
cells and also have immunomodulatory potential through
upregulation of IL-7 cytokine, which research has shown to
play a major role in cancer immunotherapy.
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Abbrevations
ANOVA, analysis of variance; CCK, cell counting kit; CD, cluster of
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fetal bovine serum; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
IEC, intestinal epithelial cells; IL, interleukin; kDa, kilodalton; P/S, penicillin/
streptomycin; PCR, polymerase chain reaction; RNA, ribonucleic acid; RPMI,
Roswell Park Memorial Institute; SEM, standard error mean; TCM, traditional
Chinese medicine; TUTCM, Tianjin University of Traditional Chinese Medicine
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